Summit Wealth Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-596
Closed -$281K 44
2023
Q4
$281K Buy
596
+79
+15% +$36.5K 0.22% 30
2023
Q3
$225K Buy
+517
New +$235K 0.2% 35
2023
Q2
Sell
-131,506
Closed 138
2023
Q1
$0 Buy
+131,506
New +$62.6M ﹤0.01% 190

Other funds holding ELV

Summit Wealth Group's ELV Position: Q1 2024 in Review

Summit Wealth Group sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 596 shares — an estimated $281K sold.

Summit Wealth Group first reported a position in ELV in Q1 2023 and held it in 3 quarters. The position peaked at $281K in Q4 2023. 1,667 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • Summit Wealth Group reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • Summit Wealth Group sold 596 Elevance Health shares in Q1 2024, an estimated $281K.
  • Summit Wealth Group first reported a position in Elevance Health in Q1 2023 and held it in 3 quarters.
  • Summit Wealth Group's Elevance Health position peaked at $281K in Q4 2023.
  • 1,667 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Summit Wealth Group's 13F filing for Q1 2024, filed 1 May 2024.